
Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals, Inc. (PHAT)
WebsitePrice
Market cap
Next catalystQ4 2026 — 12-week blinded treatment topline resultsVOQUEZNA — pHalcon-EoE-201 · Phase 2 dataCompany release ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
Other pipelines
Approved / commercial
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved